Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-07-22

FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for insulin lispro from Eli Lilly, adding to the approved lispro product line.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • insulin lispro (insulin lispro)

Snippet

SUPPL AP for INSULIN LISPRO (INSULIN LISPRO)